BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8783670)

  • 21. Combined-modality therapy of locally advanced cervical cancer.
    Rose PG
    J Clin Oncol; 2003 May; 21(10 Suppl):211s-217s. PubMed ID: 12743137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
    Nezhat F; Wadler S; Muggia F; Mandeli J; Goldberg G; Rahaman J; Runowicz C; Murgo AJ; Gardner GJ
    Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperfractionated radiation therapy plus chemotherapy in locally advanced cervical cancer: results of two phase I dose-escalation Gynecologic Oncology Group trials.
    Calkins AR; Harrison CR; Fowler WC; Gallion H; Mangan CE; Husseinzadeh N; Alvarez RD; Mychalczak B; Podczaski E
    Gynecol Oncol; 1999 Dec; 75(3):349-55. PubMed ID: 10600288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer.
    Novetsky AP; Einstein MH; Goldberg GL; Hailpern SM; Landau E; Fields AL; Mutyala S; Kalnicki S; Garg M
    Gynecol Oncol; 2007 Jun; 105(3):635-40. PubMed ID: 17331568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
    Komaki R; Lee JS; Milas L; Lee HK; Fossella FV; Herbst RS; Allen PK; Liao Z; Stevens CW; Lu C; Zinner RG; Papadimitrakopoulou VA; Kies MS; Blumenschein GR; Pisters KM; Glisson BS; Kurie J; Kaplan B; Garza VP; Mooring D; Tucker SL; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1369-77. PubMed ID: 15050312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
    Mundt AJ; Rotmensch J; Waggoner SE; Yamada SD; Fleming GF
    Gynecol Oncol; 2004 Mar; 92(3):801-5. PubMed ID: 14984944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential of amifostine: from cytoprotectant to therapeutic agent.
    Santini V; Giles FJ
    Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open label multicenter trial of subcutaneous amifostine (Ethyol) in the prevention of radiation induced esophagitis and pneumonitis in patients with measurable, unresectable non-small cell lung cancer.
    Mehta V
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):42-6. PubMed ID: 15726522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
    Movsas B; Scott C; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Smith C; Axelrod R; Sarna L; Wasserman T; Byhardt R
    J Clin Oncol; 2005 Apr; 23(10):2145-54. PubMed ID: 15800308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study.
    Vrdoljak E; Prskalo T; Omrcen T; Situm K; Boraska T; Frleta Ilić N; Janković S; Hamm W
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):824-9. PubMed ID: 15708262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
    Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
    Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.
    Loizzi V; Cormio G; Vicino M; Selvaggi L
    Gynecol Obstet Invest; 2008; 65(2):96-103. PubMed ID: 17878736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.
    Wadler S; Beitler JJ; Rubin JS; Haynes H; McGill F; Rozenblit A; Goldberg G; Cohen C; Speyer J; Runowicz C
    J Clin Oncol; 1993 Aug; 11(8):1511-6. PubMed ID: 8393096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14.
    Ang KK; Harris J; Garden AS; Trotti A; Jones CU; Carrascosa L; Cheng JD; Spencer SS; Forastiere A; Weber RS
    J Clin Oncol; 2005 May; 23(13):3008-15. PubMed ID: 15860857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116.
    Small W; Winter K; Levenback C; Iyer R; Hymes SR; Jhingran A; Gaffney D; Erickson B; Greven K
    Int J Gynecol Cancer; 2011 Oct; 21(7):1266-75. PubMed ID: 21892091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of a phase II trial of concurrent chemoradiation in the treatment of locally advanced carcinoma of uterine cervix: an experience from India.
    Saibishkumar EP; Patel FD; Sharma SC
    Bull Cancer; 2005 Jan; 92(1):E7-12. PubMed ID: 15811845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.